Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease.

BACKGROUND--There is uncertainty regarding the use of monotherapy or combination therapy with beta 2 agonists and anticholinergic drugs in patients with chronic obstructive pulmonary disease (COPD). The measurement of forced expiratory volume in one second (FEV1) or relaxed vital capacity (RVC) in t...

Descripción completa

Detalles Bibliográficos

Publicado en:	Thorax
Autores principales:	Newnham, D. M., Dhillon, D. P., Winter, J. H., Jackson, C. M., Clark, R. A., Lipworth, B. J.
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMJ Publishing Group 1993
Materias:	Research Article
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC464905/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8296260/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.48.11.1151
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!